Acadia Healthcare Company, Inc. (ACHC) 2017 Q4 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • As a reminder, this call is being recorded. Please proceed.

    提醒您,本次電話會議正在錄音。請繼續。

  • William Brent Turner - President

    William Brent Turner - President

  • Good morning. I'm Brent Turner, President of Acadia Healthcare, and I'd like to welcome you to our fourth quarter 2017 conference call.

    早安。我是 Acadia Healthcare 總裁 Brent Turner,歡迎各位參加我們 2017 年第四季電話法說會。

  • To the extent any non-GAAP financial measures are discussed in today's call, you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by viewing yesterday's news release under the Investors link.

    若今日電話會議中討論任何非 GAAP 財務衡量指標,您亦可在我們網站上,透過「投資人」連結查看昨日新聞稿,以取得該指標與依 GAAP 計算之最直接可比財務衡量指標的調節表。

  • This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2018 and beyond. For this purpose, any statements made during the call that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements. You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in our fourth quarter news release, and consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義的前瞻性陳述,其中包括但不限於關於 Acadia 對 2018 年及其後各季度與年度預期財務表現的陳述。就此而言,會議中所作任何非歷史事實之陳述,均可能被視為前瞻性陳述。在不限制前述內容的情況下,「相信」、「預期」、「計畫」、「預估」及類似用語旨在識別前瞻性陳述。特此提醒您,這些陳述可能受到(其中包括)Acadia 向美國證券交易委員會(SEC)提交之文件及我們第四季新聞稿中所載重要因素的影響,因此實際營運與結果可能與前瞻性陳述中討論之結果存在重大差異。本公司不承擔公開更新任何前瞻性陳述之義務,無論係因新資訊、未來事件或其他原因。

  • At this time, for opening remarks, I'll now turn the conference over to our Chairman and Chief Executive Officer, Joey Jacobs.

    現在,開場致詞部分,我將把會議交給我們的董事長兼執行長 Joey Jacobs。

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Thanks, Brent. Good morning, and thank you for being with us today for our fourth quarter conference call. In addition to Brent, I'm here today with our Chief Financial Officer, David Duckworth, and other members of our executive management team. David and I each have some remarks about the fourth quarter and our outlook for 2018, then we'll open the line for your questions.

    謝謝,Brent。早安,感謝各位今天參加我們的第四季電話會議。除了 Brent 之外,今天與我一同出席的還有我們的財務長 David Duckworth,以及其他執行管理團隊成員。David 和我將分別就第四季表現與 2018 年展望發表一些看法,之後我們將開放提問。

  • We are pleased with the overall performance for the fourth quarter. Our results met or exceeded our revised expectations. Total same facility revenue for the fourth quarter of 2017 increased 5.6% as compared to the fourth quarter of 2016. U.S. same facility revenue for the quarter increased 6.6% from the fourth quarter of 2016. U.K. same facility revenue for the quarter increased 3.7% from the fourth quarter of 2016.

    我們對第四季的整體表現感到滿意。我們的結果達到或超過我們修正後的預期。2017 年第四季整體同院(same facility)營收較 2016 年第四季成長 5.6%。本季美國同院營收較 2016 年第四季成長 6.6%。本季英國同院營收較 2016 年第四季成長 3.7%。

  • During 2017, we added 750 beds to existing and 2 new facilities, which contributed significantly to the increase in total same facility revenue for the fourth quarter. This included the addition of 398 beds during the fourth quarter, with 258 of these beds added in the U.S. and 140 added in the U.K.

    2017 年期間,我們在既有設施以及 2 家新設施新增了 750 張床位,對第四季整體同院營收的成長貢獻顯著。其中第四季新增 398 張床位,包括美國新增 258 張、英國新增 140 張。

  • For 2018, we expect to add more than 800 beds to existing and new facilities, with about 75% of these beds expected in the U.S. We have 2 joint ventures and 2 company-owned de novos scheduled to open in 2018. While we did complete the acquisition of a 36-bed education facility in the U.K. during the fourth quarter, we expect our capital priorities for 2018 will be focused on bed additions to our existing facilities, building joint venture and company-owned de novo facilities and debt repayment.

    展望 2018 年,我們預期在既有與新設施新增超過 800 張床位,其中約 75% 預計位於美國。我們有 2 個合資案與 2 個公司自建(de novo)案預定於 2018 年開幕。雖然我們在第四季完成收購英國一處 36 床的教育設施,但我們預期 2018 年的資本配置重點將聚焦於既有設施的床位擴增、興建合資與公司自建(de novo)設施,以及償還債務。

  • We have entered 2018 optimistic about our prospects for growth during the year. We remain focused on the U.K. operations. In the short term, we are working to mitigate the impact of a rollout to Italy, weak rebound in census in the latter month of 2017 and the increased cost of agency labor.

    我們以對 2018 年成長前景樂觀的心態進入新的一年。我們仍專注於英國的營運。短期內,我們正致力於降低義大利推行(rollout)、2017 年後期入住率(census)回升疲弱,以及派遣人力(agency labor)成本上升所帶來的影響。

  • Longer term, we expect to manage through both of these issues by investing in initiatives to drive increased census, recruit additional nurses and clinical staff, improve our real-time labor management and negotiate appropriate reimbursement for the care we provide.

    從較長期來看,我們預期將透過投資各項措施來因應這兩項議題,包括推動入住率提升、招募更多護理與臨床人員、改善即時人力管理,以及就我們提供的照護服務協商適當的給付(reimbursement)。

  • We have implemented several initiatives to help manage our agency labor, including a new reporting tool. Facilities are now required to track their agency hours on a daily basis. With the help from these initiatives, we are starting to see improvement in our agency labor. In January, agency expense as a percent of total labor declined to 11.4% from 12% in December. We expect this improvement to continue throughout 2018. As a percentage of revenue, total labor cost, including agency labor, are expected to decline from 65% in the fourth quarter of 2017 to less than 64% for 2018.

    我們已推行多項措施以協助管理派遣人力,包括新的報表工具。各院所目前被要求每日追蹤其派遣工時。在這些措施的協助下,我們開始看到派遣人力使用情況有所改善。1 月份,派遣費用占總人力成本的比例由 12 月的 12% 降至 11.4%。我們預期此改善將在 2018 年持續。以營收百分比計,包含派遣人力在內的總人力成本,預期將由 2017 年第四季的 65% 降至 2018 年低於 64%。

  • We would also like to provide some guidelines for our same facility metrics in 2018. We expect same facility revenue to grow in the mid-single digits. Same facility EBITDA margins are expected the same or slightly up. Despite some expected challenges in 2018, favorable dynamics related to demand and capacity, access and parity continue to support the growth potential of behavioral health care in the U.S. and the U.K. markets. We believe Acadia is well positioned to leverage these dynamics to create further long-term growth in our earnings and shareholder value.

    我們也想就 2018 年同院指標提供一些指引。我們預期同院營收將以中個位數百分比成長。同院 EBITDA 利潤率預期持平或小幅上升。儘管 2018 年預期仍有一些挑戰,但與需求與產能、可近性(access)與同等待遇(parity)相關的有利動態,仍持續支持行為健康照護在美國與英國市場的成長潛力。我們相信 Acadia 已具備良好定位,可運用這些動態,進一步推動獲利與股東價值的長期成長。

  • Thanks for your time this morning and your interest in Acadia. Now here's David Duckworth to take you through the financials.

    感謝各位今早撥冗,以及對 Acadia 的關注。接下來請 David Duckworth 帶各位回顧財務表現。

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • Thanks, Joey, and good morning. The company's revenue for the fourth quarter of 2017 was $724.5 million, an increase of 3.1% from $702.9 million for the fourth quarter of 2016. Adjusted earnings per diluted share increased 3.4% to $0.61 for the fourth quarter of 2017 compared with $0.59 for the fourth quarter of 2016. Adjusted EPS for the latest quarter excludes the tax benefit of $20.2 million due to the impact of the Tax Cuts and Jobs Act and transaction-related expenses of $5.4 million. Also, the 22 facilities in the U.K. that were divested on November 30, 2016, contributed revenue of approximately $30 million and adjusted EPS of approximately $0.05 to the result of operations for the fourth quarter of 2016.

    謝謝,Joey,早安。公司 2017 年第四季營收為 7.245 億美元,較 2016 年第四季的 7.029 億美元成長 3.1%。2017 年第四季調整後稀釋每股盈餘(Adjusted EPS)較 2016 年第四季的 0.59 美元成長 3.4% 至 0.61 美元。最新一季的調整後 EPS 排除因《減稅與就業法案》(Tax Cuts and Jobs Act)影響所產生的 2,020 萬美元稅務利益,以及 540 萬美元的交易相關費用。此外,於 2016 年 11 月 30 日出售的英國 22 家設施,對 2016 年第四季營運結果貢獻約 3,000 萬美元營收及約 0.05 美元的調整後 EPS。

  • Acadia's total same facility revenue growth for the fourth quarter was 5.6%, which included a 2.4% increase in patient days and a 3.1% increase in revenue per patient day. Total same facility EBITDA margin was 24.5% compared with 24.9% for the fourth quarter of 2016.

    Acadia 第四季整體同院營收成長為 5.6%,其中包含病患日數(patient days)增加 2.4%,以及每病患日營收增加 3.1%。整體同院 EBITDA 利潤率為 24.5%,相較 2016 年第四季的 24.9%。

  • Same facility revenue for our U.S. operations increased 6.6% for the fourth quarter compared with the fourth quarter of 2016 on a 3.1% increase in patient days and a 3.3% increase in revenue per patient day. Same facility EBITDA margin was 26.3% for the fourth quarter, even with the fourth quarter of 2016.

    我們美國業務的同店營收在第四季較2016年第四季增加6.6%,主要來自病患日數增加3.1%以及每病患日營收增加3.3%。第四季同店EBITDA利潤率為26.3%,與2016年第四季持平。

  • Same facility revenue for our operations in the U.K. increased 3.7% for the fourth quarter compared with the fourth quarter of 2016. Patient days increased 1.5% and revenue per patient day grew 2.2%. Same facility EBITDA margin in the U.K. was 21.1% for the fourth quarter compared to 22.3% for the fourth quarter of 2016. The company's consolidated adjusted EBITDA for the fourth quarter of 2017 was $153.5 million or 21.2% of revenue.

    我們英國業務的同店營收在第四季較2016年第四季增加3.7%。病患日數增加1.5%,每病患日營收成長2.2%。英國同店EBITDA利潤率第四季為21.1%,相較2016年第四季的22.3%。公司2017年第四季合併調整後EBITDA為1.535億美元,約占營收的21.2%。

  • Acadia's tax rate on adjusted income from continuing operations before income taxes was 23.7% for the full year 2017, which reflects a tax rate of 19.9% for the fourth quarter compared with 18% for the fourth quarter of 2016. Acadia's operating cash flow from continuing operations was $128.7 million for the fourth quarter of 2017, a 20.7% increase from $106.6 million for the fourth quarter of 2016.

    Acadia在2017年全年持續營運(所得稅前)調整後收益的稅率為23.7%,其中第四季稅率為19.9%,相較2016年第四季的18%。Acadia 2017年第四季持續營運的營業活動現金流為1.287億美元,較2016年第四季的1.066億美元增加20.7%。

  • Turning to our financial guidance, and as announced in yesterday afternoon's news release, we have established our 2018 financial guidance based on our results for the fourth quarter and full year 2017 and our outlook for 2018. Our guidance includes: revenue in a range of $3.04 billion to $3.08 billion; adjusted EBITDA in a range of $637 million to $644 million; adjusted diluted EPS in a range of $2.42 to $2.48; and an exchange rate of $1.35 per British pound sterling; and a tax rate of approximately 21%. We expect adjusted earnings per diluted share for the first quarter of 2018 in a range of $0.47 to $0.49. Our financial guidance does not include the impact from any future acquisitions or transaction-related expenses.

    接著談我們的財務指引,如同昨天下午新聞稿所宣布,我們已根據2017年第四季與全年業績,以及對2018年的展望,制定2018年財務指引。指引包括:營收介於30.4億至30.8億美元;調整後EBITDA介於6.37億至6.44億美元;調整後稀釋每股盈餘(EPS)介於2.42至2.48美元;匯率假設為每英鎊1.35美元;以及稅率約21%。我們預期2018年第一季調整後稀釋每股盈餘介於0.47至0.49美元。我們的財務指引未包含任何未來併購或交易相關費用的影響。

  • This concludes our prepared remarks this morning, and thank you for being with us. I'll now ask Rochelle to open the floor for your questions.

    以上為我們今天上午的預先準備發言,感謝各位與會。接下來我請Rochelle開放提問。

  • Operator

    Operator

  • (Operator Instructions) And we'll take Brian Tanquilut with Jefferies.

    (接線員指示) 接下來我們請Jefferies的Brian Tanquilut提問。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • David, first question for you. As I think about your guidance, you're using the FX at $1.35. The average is, year-to-date so far, at about $1.39. How should I think about your conservatism? Is that what that is and also, the added 350 beds in Q4 alone -- or almost 400 beds in Q4 alone. So putting all that together, I mean, should I be thinking about the guidance as having enough dose of conservatism in there in -- just putting those 2 factors in?

    David,我的第一個問題想請教你。就你們的指引來看,你們使用的匯率假設是1.35美元。而今年迄今的平均大約在1.39美元。我該如何理解你們的保守程度?這是否就是你們保守的地方?另外,光是第四季就新增了350張床位——或接近400張床位。把這些因素合在一起看,我是否應該把指引理解為已經納入足夠的保守性——就這兩個因素而言?

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • I think, Brian, on the forecast that we have for the exchange rate, we do look at the history of it, and it has been strong for several months now. But we do like to build in some conservatism. So you're right that, if we can maintain the exchange rate where it is today, there is some upside that is built into our guidance. And then on the new beds, that's factored into a ramp-up over the course of 2018. We had a great quarter, been adding beds to our facilities and opening 2 new facilities during the quarter. And the ramp-up in those new facilities, the new beds is factored into our guidance.

    Brian,關於我們對匯率的預測,我們會參考其歷史走勢,而它過去幾個月確實一直偏強。但我們也希望在其中納入一些保守性。所以你說得沒錯,如果我們能維持目前的匯率水準,我們的指引中確實包含一些上行空間。至於新增床位,這已納入2018年全年逐步爬坡的假設。我們第四季表現很不錯,持續在既有機構增床,並在該季開設了2家新機構。這些新機構與新增床位的爬坡效益都已反映在我們的指引中。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • Got you. And then my follow-up for Joey. As I think about the Cures bill and then the recent tax bill that passed with opioid addiction funding, how are you thinking about the flow-through of that? And how Acadia will realize the benefit from the incremental dollars the government's throwing at the opioid epidemic?

    了解。接著我想追問Joey。就《Cures法案》以及近期通過、包含鴉片類成癮資金的稅改法案而言,你們如何看待這些資金的傳導效應?Acadia將如何從政府投入鴉片類藥物危機的增量資金中受益?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Well, obviously, it's a positive that -- not only the Cures Act, but they did put additional monies in during the budgeting process. And that the federal government wants to help the states on this issue. Unfortunately, you have to go through the states. The money will go to the states, and they will find a way to get it for treatment. We think all the money should go towards the treatment process. We've had some early successes in 3 states, where the Cures Act has made it through the state and is actually being used today to give better treatment, more access to the patients. So we think the other states are going to follow. So with a couple of those being the largest states in the country population-wise, that they are aggressively moving towards getting that money to work in treating the patients. And we have lobbyists in every state, working with the states and communicating our position on how we think this money should be used. We know that some of the money will go towards education, which it should. But really, it should go to the treatment of these patients, and so it's a positive. There's no way we can quantify it today. We could, for the 3 states that we're already in, we have a pretty good idea how much money that is. But we need more states to actually get it implemented and start flowing the funds. But it's absolutely a positive and absolutely something this country needs. And since we're the largest provider, we think we will be the largest recipient of the monies to expand access and treatments for these patients.

    嗯,顯然這是正面的——不只是《Cures法案》,他們也在預算編列過程中投入了額外資金。聯邦政府希望在這個議題上協助各州。不過不幸的是,你必須透過各州來執行。資金會撥給各州,而各州會想辦法把資金用於治療。我們認為所有資金都應該用在治療流程上。我們在3個州已取得一些早期成果,《Cures法案》的資金已在州層級落地,且目前確實用於提供更好的治療、讓病患有更多可近性。因此我們認為其他州也會跟進。其中有幾個州以人口來看是全國最大的一些州,他們正積極推動讓這些資金發揮作用,用於治療病患。我們在每個州都有遊說團隊,與各州合作並溝通我們對於這筆資金應如何使用的立場。我們知道部分資金會用於教育,這也應該如此。但更重要的是,資金應用於這些病患的治療,因此這是正面的。目前我們無法量化其影響。就我們已經進入的那3個州而言,我們大致知道金額規模。但我們需要更多州真正完成落地並開始讓資金流動。不過這絕對是正面訊息,也絕對是這個國家所需要的。而由於我們是最大的服務提供者,我們認為我們將會是最大的資金受益者,以擴大這些病患的可近性與治療服務。

  • Operator

    Operator

  • And next, we move on to A.J. Rice with Crédit Suisse.

    接下來我們請Crédit Suisse的A.J. Rice提問。

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • First of all, let me just ask a little bit about your comments around the debt. You said that part of the priorities for cash flow were paying down debt. Is there an updated target? I think, at the end of the quarter, you were at -- or year, you were at 4.9x net debt-to-EBITDA. Do you have a target? And is there any opportunity or assumptions you're making about reworking where you're borrowing is to maybe get better benefit from the tax reform? I think you had a little bit of a mismatch. And if you'll assume that you reduce the refinancing or something, that would make a difference on that?

    首先,我想先問一下你們對於債務的評論。你提到現金流的優先事項之一是償還債務。是否有更新的目標?我記得在季末——或年末——你們的淨負債對EBITDA約為4.9倍。你們有目標值嗎?另外,你們是否有任何機會或假設,會透過調整借款結構來更好地受益於稅改?我認為你們之前有一些不匹配的情況。如果你們假設降低再融資或做些調整,是否會對此產生影響?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Yes, A.J., I think, our leverage at the end of the year is actually a little above 5x. And if you look through -- if you read through our guidance and the growth in EBITDA combined with the debt paydown, we expect to be below 5x during 2018. And we are working and thinking about the debt restructurings, where we can get some benefit. We do have a slight amount of debt that is excluded from the deductibility. And any improvement we can do there will help us maximize our tax benefit. So we're working on some of those items as well.

    是的,A.J.,我認為我們在年底的槓桿比率實際上略高於 5 倍。而如果你仔細看——如果你讀過我們的指引,以及 EBITDA 的成長再加上債務償還,我們預期在 2018 年期間會降到 5 倍以下。我們也正在推動並思考債務重整,在那裡我們可以取得一些效益。我們確實有少量債務不符合利息可扣抵的規定。而我們在那方面能做的任何改善,都將有助於我們將稅務利益最大化。所以我們也在處理其中一些事項。

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • I guess, is there an assumption in the interest expense for 2018 that assumes either a refinancing or you'll assume some step-up in interest rates in any way?

    我想問,2018 年的利息費用假設中,是否有納入再融資的假設,或是以任何方式假設利率會上升?

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • A.J., this is David. We are building in some increase in our interest expense for next year. We're projecting interest expense of just over $180 million. And that does factor in what rates are projected to do. We are also planning and have factored into the guidance that we would make some debt repayments. We have $35 million of mandatory debt repayments for the year. But it would expect cash flows to support that we can make more debt repayment than that. And the tax rate, our 21% tax rate does factor in that there's about $15 million of interest, but that's the tax effect of the disallowed interest. But as Brent said, we are planning to minimize that effect and think that as earnings grow, that the impact of that would be reduced as we think ahead to 2019 and going forward.

    A.J.,我是 David。我們在明年的利息費用中已納入一些增加。我們預估利息費用略高於 1.8 億美元。而這確實反映了對利率走勢的預測。我們也在規劃,並已在指引中納入我們將進行部分債務償還。我們今年有 3,500 萬美元的強制性債務償還。但我們預期現金流可支持我們償還更多債務。至於稅率,我們 21% 的稅率確實已反映約 1,500 萬美元的利息——但那是不可扣抵利息的稅務影響。不過如 Brent 所說,我們計畫將該影響降到最低,並認為隨著獲利成長,展望 2019 年及之後,該影響會降低。

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • Okay. And maybe just real quick, my other question. In your prepared remarks, I think Joey's comments maybe in -- it sounds like now, you're describing the labor issues. The agency is almost more what I would describe as a management and needing more tools to manage that as opposed to just, say, a market situation that there's not much you can do about. Is that the right way to characterize the way you're looking at it now? And you did refer to the census in the U.K. rebounding a little slower. Is there any update or any discussions with NHS that suggests that maybe that can get corrected?

    好的。另外很快再問一個問題。在你們事先準備的談話中,我想 Joey 的評論可能在——聽起來你們現在是在描述勞動力問題。人力派遣(agency)似乎更像是我會形容的管理問題、以及需要更多工具來管理,而不只是例如市場情況、你們幾乎無能為力的那種。這樣描述你們目前的看法是否正確?你也提到英國的入住人數(census)回升得稍微慢一些。是否有任何更新或與 NHS 的討論顯示,這可能可以被修正?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Sure, A.J. Let me tackle the late -- agency costs first. There still is an acute shortage of nurses in the U.K. But through better management and some initiatives that we have started, we're beginning to see the benefit of that. But there is a crisis about clinical and nurse agency -- nurses there that won't go away any time soon. Saying that, some of these shortage is in isolated markets. And so it's not totally across the U.K. It's in some isolated markets. Some of the rural markets are very difficult. There's not the nurse there in the community that we need, so we have to relocate the nurse there and take it -- take the approach there. And then some of the urban areas, we have a couple of locations where there's more of a nurse -- nursing shortage. But we're working through that. Now we're very pleased to see the monthly progress that our team in the U.K. is doing, and we want them to stay focused. We are doing a better job in using our part-time and full-time employees that need -- that would like to work an additional shift. So if we can get more of our own internal employees to do that, then obviously, that replaces the agency expense. We are meeting with the minister -- we have met with the minister of health and other government agency officials there. And there's a lot of talk about, should the nurse staffing companies be capped in how much they could charge a facility, whether it's our facilities or a med/surg facility. So there's talk like that. There is also talk about how can we do an exception or a workaround the issue of migrating into the U.K. So we see positive signs. And we're going to take them, and we're going to work real hard. We're doing a better job internally managing it than we did, say, in the second and third quarter of last year. So I'm upbeat there, but we have to execute. We have to execute there. And then the latter part of your question was?

    當然,A.J. 我先處理後面——先談人力派遣成本。英國仍然存在嚴重的護理人員短缺。但透過更好的管理以及我們已啟動的一些措施,我們開始看到其效益。不過,臨床與護理派遣——那邊的護理人力派遣危機短期內不會消失。話雖如此,部分短缺發生在特定的市場。所以並非全英國普遍如此,而是在一些特定市場。有些鄉村市場非常困難。社區裡沒有我們需要的護理人員,因此我們必須把護理人員調派過去,並採取——採取那樣的做法。另外在一些都會區,我們有幾個據點也有較明顯的護理——護理人力短缺。但我們正在逐步解決。我們很高興看到英國團隊每月的進展,也希望他們保持專注。我們在運用兼職與全職員工方面做得更好——那些需要——也願意多上一個班的員工。因此如果我們能讓更多內部員工這麼做,顯然就能取代派遣費用。我們正在與衛生大臣會面——我們已與衛生大臣及其他政府機關官員會面。目前有很多討論,例如是否應限制護理派遣公司對機構可收取的費用上限,不論是我們的機構或是內外科(med/surg)機構。所以有這類討論。也有討論如何針對移民進入英國的問題做例外處理或替代方案。因此我們看到一些正面跡象。我們會把握這些跡象,並且會非常努力。在內部管理方面,我們做得比去年第二、第三季時更好。所以我對此感到樂觀,但我們必須執行。我們必須在那裡落實執行。那你問題的後半段是?

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • Relative to the census rebound in the U.K.

    關於英國入住人數(census)回升的情況。

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • The U.K., is -- as we mentioned on previous calls, the U.K. is going through a transition process of letting the local areas determine the patients and the flow of patients. And they've started. And it should have been done by now, we think. But they haven't got it completed. And as we look -- we think -- our team in the U.K. estimates that it will take another year before these local communities fully transition this in. Now saying that, our education business is doing extremely well. Our health care business is now hitting all-time highs on their census. So there's, internally, over in the U.K., there are some bright spots. And we want to continue to do that. We're taking some of the unused beds and retrofitting them to meet the needs of the local communities and NHS. And we'll do more of those this year, where we will put an existing bed in service because we would be retooling it to meet a need that we hadn't been meeting. So there's a lot of positives going on, and we take it a day at a time. And we'll be over there with our [MOR] with the U.K. this week. We'll be over there in 3 weeks to visit with them again and go over their MOR for February. So we're cautiously optimistic, and we take it a day at a time.

    英國——如我們在先前的電話會議中提到,英國正在進行一個轉型流程,讓各地方區域來決定病患以及病患流向。而他們已經開始了。我們認為這本應該到現在就完成。但他們尚未完成。而就我們觀察——我們認為——英國團隊估計,還需要再一年,這些地方社區才會完全完成轉型。話雖如此,我們的教育業務表現非常好。我們的醫療照護業務在入住人數(census)方面正創下歷史新高。所以在英國內部,有一些亮點。我們希望持續推進。我們正把一些未使用的床位重新整修,以符合地方社區與 NHS 的需求。今年我們也會做更多這類工作,也就是把既有床位重新投入使用,因為我們會重新配置它以滿足我們過去未能滿足的需求。所以有很多正面的事情正在發生,我們一天一天地推進。而我們本週會在那邊與英國的 [MOR] 一起。三週後我們會再去拜訪他們一次,並檢視他們二月份的 MOR。所以我們審慎樂觀,也是一天天地推進。

  • Operator

    Operator

  • And next, we move on to Ryan Daniels with William Blair.

    接下來,我們進入 William Blair 的 Ryan Daniels。

  • Nicholas Mark Hiller - Associate

    Nicholas Mark Hiller - Associate

  • This is Nick Hiller in for Ryan Daniels. Just on the joint ventures in the U.S., do you have enough critical mass there where, I mean, they could start to service reference facilities, if you will? And is that stimulating maybe even more demand from novel partners?

    我是代替 Ryan Daniels 的 Nick Hiller。就美國的合資企業而言,你們那邊是否已具備足夠的規模,也就是說,它們可以開始為所謂的參考機構(reference facilities)提供服務?而這是否也在刺激、甚至帶來更多來自新型合作夥伴的需求?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Absolutely. We have enough facilities up and running that we use them as references to potential joint venture partners. And we've got 2 more of those coming online this year. At one end, here in Tennessee and Chattanooga with Erlanger medical center, and one in Ohio with the Mount Carmel facility. So yes, we do use our existing ones for references, and they are bringing new opportunities to us. And we have quite a few joint ventures that are in different stages of approval process and very optimistic that we will continue to execute here in our growth strategy.

    當然。我們已有足夠多的設施投入營運,因此我們會把它們作為潛在合資夥伴的參考案例。而且今年還會再有兩個這樣的設施開始營運。一個在田納西州的查塔努加,與 Erlanger 醫療中心合作;另一個在俄亥俄州的 Mount Carmel 設施。所以是的,我們確實會用現有設施作為參考,它們也為我們帶來新的機會。此外,我們有相當多的合資案正處於不同階段的核准流程中,我們非常樂觀,認為我們將能持續落實我們的成長策略。

  • Nicholas Mark Hiller - Associate

    Nicholas Mark Hiller - Associate

  • And then just on the breakdown between price and volume in your 2018 U.S. guidance, could you give that also for the U.K. as well?

    另外,關於你們 2018 年美國指引中價格與量的拆分,你也能提供英國的拆分嗎?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • I can. We think mid-single digits for the total company for same facility revenue growth. We expect patient days to grow in the 4% to 6% range for the year once all these new beds get online, and we get the patients there. And we will have a, hopefully, a 2% rate increase here and overall in the U.S. And that will give us that 5% to 7% same-store revenue growth for the year. In the U.K., it will be just slightly less, that we do expect positive patient day growth in the 2%, 3% range. If we get our beds retooled over to the services that are needed and that the NHS continues to improve on the flow of patients there, and then we expect about a 1.5% rate increase for the U.K. So we expect their revenue -- same-store revenue to grow in the 4% to 6% range. So we feel good about both the U.K. and the U.S. and the beds we've got and the executions and the teams that we have in place.

    可以。我們認為就同一設施營收成長而言,全公司大約是中個位數百分比。一旦這些新床位全部上線、並且我們把病人導入,我們預期全年病人日將成長 4% 到 6%。而在美國,我們希望費率能上調 2%,整體而言也是如此。這將帶來全年 5% 到 7% 的同店營收成長。在英國會略低一些,我們確實預期病人日成長為正,約在 2% 到 3% 的區間。如果我們能把床位重新調整到所需的服務上,且 NHS 持續改善那邊病人的流動,我們預期英國的費率上調約 1.5%。因此我們預期其營收——同店營收——將成長 4% 到 6%。所以我們對英國與美國都很有信心,包含我們現有的床位、執行力,以及已到位的團隊。

  • Operator

    Operator

  • We'll move on to Chris Rigg with Deutsche Bank.

    接下來我們請德意志銀行的 Chris Rigg 提問。

  • Christian Douglas Rigg - Research Analyst

    Christian Douglas Rigg - Research Analyst

  • Just wanted to follow up on that last question. So if you're going to get 4% to 6% same store in the U.K., can you sustain the margin at that level? Or will you still see margin pressure because of the labor dynamic?

    我想跟進上一個問題。所以如果你們在英國同店能達到 4% 到 6%,你們能把利潤率維持在那個水準嗎?還是會因為人力的動態而持續看到利潤率壓力?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Well, we will -- the labor dynamic will continue to put pressure on us. Now we expect margins to improve. That's our expectation, and that is our budget, so even in the U.K. and the U.S. Now it may only be 20 basis points of margin improvement, but we expect positive margin improvement in both countries. Now the labor cost is an issue, but for example, we spent less labor dollars in January than we did in December. So January was off to a good trend in how we're doing and working with reducing our agency costs. So if we can continue to build on that through the year, then we're there. We're there.

    嗯,我們——人力的動態仍會持續對我們造成壓力。不過我們預期利潤率會改善。這是我們的預期,也是我們的預算,因此英國與美國都是如此。現在可能只改善 20 個基點,但我們預期兩個國家都會有正向的利潤率改善。人力成本確實是個問題,但例如,我們 1 月的人力支出就比 12 月少。所以 1 月在我們降低派遣人力成本方面,開局趨勢不錯。如果我們能在全年持續累積這個成果,那我們就能達成。我們能達成。

  • Christian Douglas Rigg - Research Analyst

    Christian Douglas Rigg - Research Analyst

  • Got you. Great. And then just in terms of the -- I mean, you talked about the leverage and that being a focus. Acquisition-wise, do you expect to see a relatively similar pace in 2018 as you did in 2017, with the focus more on the organic and JV side?

    了解。很好。另外就——我是說,你談到槓桿並把它作為重點。在併購方面,你預期 2018 年的步調會和 2017 年相對類似嗎?重點會更偏向內生成長與合資(JV)嗎?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • It will be more on the organic and JV side. I'm not saying we wouldn't do an acquisition. If we want to do an -- if someone was to say, Joey, you can make one acquisition, and what would you buy? I would probably buy an acquisition that would help on the opiate treatment. We have about 115 facilities that do that. I would make an acquisition right there because of all the money the federal government is taking -- they're giving, the demand of these services. But if we don't do that, that's okay, too. We have plenty of growth through our bed builds and through the joint ventures. So we're in good shape for growing the company.

    會更偏向內生成長與合資(JV)。我不是說我們不會做併購。如果我們想做一筆——如果有人說,Joey,你可以做一筆併購,你會買什麼?我可能會買一個能在鴉片類藥物治療方面有所助益的標的。我們大約有 115 家設施在做這個。我會在那裡做一筆併購,因為聯邦政府投入——他們提供的資金很多,而且這些服務的需求也很大。但如果我們不做,也沒關係。我們透過擴建床位以及合資案,仍有充足的成長動能。所以我們在公司成長方面狀況很好。

  • Operator

    Operator

  • And next, we move on to Ralph Giacobbe with Citi.

    接下來我們請花旗的 Ralph Giacobbe 提問。

  • Ralph Giacobbe - Director

    Ralph Giacobbe - Director

  • Just wanted to ask a little bit about the 1Q guide. If I try to back into an EBITDA number, it looks like it would imply EBITDA sort of flat year-over-year. Not sure if there's something I'm missing in terms of a difficult comp or if you're seeing something early in the year that's maybe causing some of that pressure. And then what would drive sort of the ramp for the growth kind of into the back half of the year?

    我想問一下第一季(1Q)的指引。如果我試著倒推一個 EBITDA 數字,看起來會意味著 EBITDA 年增大致持平。不確定我是否漏了什麼,例如比較基期很難,或是你們在年初看到一些情況可能造成部分壓力。另外,到了下半年,成長加速的爬坡會由什麼來驅動?

  • William Brent Turner - President

    William Brent Turner - President

  • Ralph, this is Brent. You might recall, in the first quarter, the company has a reset of all of the employee-related taxes. And so we tend to have a much higher labor cost because of those employee-related taxes in the first quarter. And then also in the first quarter, as you heard in the remarks, we have 2 de novos that are open -- that have opened. And any time we open a de novo, there's some early losses. So that's going to weigh in more significantly on this year's first quarter. But then as the beds become -- the new beds become occupied, you see that ramp through the balance of the year. So that -- those are the primary components of the first quarter.

    Ralph,我是 Brent。你可能記得,在第一季,公司會重置所有與員工相關的稅負。因此第一季因為這些員工相關稅負,我們的人力成本通常會高很多。另外第一季,如同你在發言中聽到的,我們有兩個新設(de novo)據點已經開——已經開幕。而每當我們開一個新設據點,初期都會有一些虧損。所以這會在今年第一季造成更顯著的影響。但隨著床位——新床位——開始被入住,你會看到在今年其餘期間逐步爬坡。所以——以上是第一季的主要構成因素。

  • Ralph Giacobbe - Director

    Ralph Giacobbe - Director

  • Okay, all right. That's helpful. And then you talked about some of the census pressure continuing in the U.K. But it seems like the referral stream is pretty positive. I mean, you had a big pop in admissions, but looked like there was more sort of a squeeze on length of stay. So just hoping you can kind of flesh out those dynamics. And if that's a phenomena that's going to continue sort of due to mix shift? Or what are the factors are at play as we think about that in '18?

    好的,了解。這很有幫助。另外你提到英國的人數(census)壓力仍在持續,但看起來轉介來源相當正向。我是說,你們收治(admissions)大幅跳升,但看起來更像是住院天數(length of stay)被壓縮。所以希望你能更詳細說明這些動態。以及這是否會因為組合轉移(mix shift)而成為會持續的現象?或者在我們看 2018 年時,還有哪些因素在發揮作用?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • The length of stay change was just really service mix or different length of stays for the different service mix. So there was nothing unusual there. We did go back and drill down there. Now the admission growth, we were glad to see that. If the NHS and the transition goes well, that could -- that should continue. And then we're doing things internally to also drive admissions to our facilities. And so we're positive about that, so there are patients that need our service. We have that documented, and that it's just a matter of getting them through the system, getting them approved for funding. And there's patients for us to have just working through the process.

    住院天數的變化其實只是服務組合,或不同服務組合對應不同住院天數所致。所以那裡沒有任何不尋常的情況。我們確實回頭去深入檢視了。至於收治成長,我們很高興看到。如果 NHS 與轉換進行順利,那可能——也應該會持續。同時我們內部也在做一些事情,來推動我們設施的收治量。因此我們對此持正面看法,確實有病人需要我們的服務。我們有文件佐證,而這只是把他們導入系統、讓他們取得資金核准的問題。我們有病人可收治,只是在流程中逐步推進。

  • Operator

    Operator

  • And next, we'll hear from Kevin Fischbeck with Bank of America Merrill Lynch.

    接下來,我們將聽取美國銀行美林(Bank of America Merrill Lynch)的 Kevin Fischbeck 提問。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • I want to go to the U.K. for a second. I guess, it sounds like some of the business lines are doing well there. But I guess, it was a little bit surprising that you're not looking to buy anything but you did buy something in the U.K. Can you just talk a little bit more about how comfortable you are with the asset mix that you have, whether there's anything that you really wouldn't want to keep investing in or potentially divest, some of those things in there that, if the right deal came along, you'd still be putting the money to work in?

    我想先談一下英國。我想聽起來你們在那邊有些業務線表現不錯。但我想,有點令人意外的是,你們說不打算買任何東西,但你們確實在英國買了一項資產。你能否再多談談你們對目前資產組合的舒適度?是否有任何你們真的不想再持續投資、或可能會考慮處分的項目?以及在那些項目中,如果出現合適的交易,你們仍會把資金投入運用嗎?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Our education line of service is doing extremely well. And that acquisition, that small acquisition, was only 35, 36 beds. I think that we made -- have actually well. So if we were to acquire something, it would -- top priority would probably be to continue to expand the education services there. Now as far as selling something, with the Priory acquisition, we got a nursing home subsidiary and we -- that is something that we would sell for the right price, and something that we have -- that we're working on to see if there is a buyer out there for that asset. And if there is and the price is right and our board approves, we would divest the nursing home piece of business.

    我們的教育服務線表現非常好。而那筆收購、那筆小型收購,只有 35、36 張床位。我認為我們做得——其實做得很好。所以如果我們要再收購,最高優先順序可能會是持續擴大那邊的教育服務。至於出售資產,透過 Priory 的收購,我們取得了一家護理之家子公司,而我們——那是我們在價格合適時會出售的項目,也是我們一直在努力尋找是否有買家願意承接該資產。如果有,而且價格合適並且董事會核准,我們會處分護理之家這塊業務。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Okay, great. And I guess, last quarter, you mentioned a couple of things, like Puerto Rico being a drag on results. I mean, obviously, you had hurricanes and fire in California. Is there anything like that, a drag in Q4? Or how to think about any of those things being a drag into 2018?

    好的,很棒。另外我想,上季你提到幾件事,例如波多黎各對業績造成拖累。我的意思是,很明顯你們在加州遇到颶風和野火。第四季是否也有類似的拖累?或者該如何看待這些因素在 2018 年是否仍會造成拖累?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • There was a drag in Q4. We didn't mention it in the press release, but it hurt us 70 basis points on patient day growth. And those patient days would have flown -- flowed through and generated maybe $0.01 to $0.02 for us in the fourth quarter. But we're -- those natural disasters happen, and they did impact us. But they're behind us now, and -- but it did, for the fourth quarter, lower our growth on patient days 70 basis points. And those 70 basis points, those patients would have flowed through -- their revenue would have flowed through to the bottom line.

    第四季確實有拖累。我們在新聞稿中沒有提到,但它讓我們的病人日(patient day)成長率受到 70 個基點的影響。而那些病人日本來會——會反映出來,並在第四季為我們帶來大約 0.01 到 0.02 美元的貢獻。但我們——自然災害就是會發生,而且確實影響了我們。不過現在都已經過去了,——但就第四季而言,它讓我們的病人日成長率降低了 70 個基點。而那 70 個基點的病人,其收入本來會——會流入並反映到最終獲利。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Great. And then just one clarification. You mentioned that labor costs, you expect it to go from 65% to 64%. Was that a U.K. labor cost number? Or is that a company labor cost number?

    很好。再請教一點釐清。你提到人力成本,你預期會從 65% 降到 64%。那是英國的人力成本數字嗎?還是公司整體的人力成本數字?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • No. That's the U.K.

    不是。那是英國的。

  • Operator

    Operator

  • And next, we move on to John Ransom with Raymond James.

    接下來,我們請 Raymond James 的 John Ransom 提問。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • A couple of things for me here. What is the corporate overhead number going to be in '18 versus '17?

    我這邊有幾個問題。2018 年相較於 2017 年,公司總部管理費(corporate overhead)會是多少?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • It's going to be up a little. And because of -- David, I'll let you answer the detail.

    會小幅上升。而且因為——David,我讓你來回答細節。

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • Sure, John. This is David. The U.S. corporate overhead projection for 2018 is around $90 million. And that does represent an increase from where we finished 2017, where we saw corporate office cost more like $70 million. And a lot of that is just bonus accrual related just for 2017, reflecting less than what would be the normal targeted annual bonus accrual amount. So our guidance does incorporate that, that would return to more of a normal level in 2018, and that would drive the corporate office cost to the $90 million level.

    當然,John。我是 David。我們對 2018 年美國公司總部管理費的預估大約是 9,000 萬美元。這確實較我們 2017 年結束時有所增加,當時我們看到總部成本大約是 7,000 萬美元。其中很大一部分只是 2017 年的獎金應計(bonus accrual)相關,反映的金額低於正常目標年度獎金應計水準。因此,我們的指引已納入這點,也就是 2018 年會回到較正常的水準,並使總部成本提高到約 9,000 萬美元。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • So that's a $20 million year-over-year change, by University of Georgia math. Secondly, what is the rate of labor inflation that you're embedding in your guidance in both U.K. and U.S.? And how does that compare to, say, a couple of years ago?

    所以按喬治亞大學的數學算法,這是年對年增加 2,000 萬美元。第二,你們在英國與美國的指引中,所內嵌的人力通膨率是多少?這與例如兩年前相比如何?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Say it one more time, John.

    John,你再說一次。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • Not counting the improvement you'll make in agency, what is your overall labor inflation number for '18? And how does that compare to a year or 2 ago?

    不把你們在派遣人力(agency)方面會做的改善算進去,你們 2018 年整體的人力通膨數字是多少?這和一、兩年前相比如何?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • John, it's easy to compare it to previous years. It would have been in the 2% range that for the company we would've seen on the labor pressure. It's probably now approaching 3% for the company as a total. And there is isolated markets where operations have come to me and to Joy. We're out of market on our latest plan here, and we do need to do some sort of an adjustment. And most of the time, it's not across-the-board adjustment. It is a specific area inside the facility that would need some tweaking on their salaries that we would do. But it's pushing towards that 3% this year as compared to 2% for the past many years, but we still have a tight control. If you were to give more than 2%, there's an extra level of approval in the company that would occur. And any exception to the salary plan would be approved by me.

    John,跟過去年度相比其實很容易。過去幾年,公司在人力成本壓力上大概會落在 2% 左右。現在公司整體可能正接近 3%。而且在某些個別市場,營運單位會來找我和 Joy。我們在最新的規劃上,薪資水準落後於市場,因此確實需要做某種調整。而多數時候,這不是全面性的調整。而是針對機構內某個特定區域,需要對薪資做一些微調,我們會去做。但今年正往 3% 推進,相較於過去多年約 2%,不過我們仍然嚴格控管。如果要給超過 2%,公司內部會有額外一層核准流程。而任何薪資計畫的例外,都會由我核准。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • And then, David, what is built into the model for de novo losses? And are you going to break this out each quarter? I hope.

    另外,David,模型中對新設(de novo)虧損納入了多少?你們會在每一季把這個拆分揭露嗎?我希望會。

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • For the de novo losses, John, well, you could see the amount if you, roughly, if you look at the difference between our same facility and our total facility result that mostly represents. But as Brent mentioned earlier, with the timing of the new facilities, we do see the first quarter reflecting some losses there from the de novos. But then over the course of the year, as we see those facilities ramp up, for the full year, maybe about $1 million loss. But again, the timing of that would be -- the first quarter would reflect a greater loss with some kind of breakeven to slightly profitable results by the second half of the year.

    關於新設(de novo)虧損,John,嗯,如果你大致看一下我們同店(same facility)與全體機構(total facility)結果之間的差異,那多半就代表那個金額。但如 Brent 先前提到的,因為新機構開設時點的關係,我們確實看到第一季會反映一些新設帶來的虧損。不過隨著這些機構在一年中逐步爬坡(ramp up),以全年來看,虧損可能約 100 萬美元。但同樣地,時點上會是——第一季反映較大的虧損,而到下半年則會接近損益兩平到略為獲利。

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • John, let me help you. During the fourth quarter, we had a $1.8 million loss on the de novos. We had 3 de novos. In the first quarter, we have in our plan a $2.1 million loss.

    John,我來補充一下。在第四季,我們的新設(de novo)虧損為 180 萬美元。我們有 3 個新設據點。在第一季,我們的計畫中納入了 210 萬美元的虧損。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • I love it when you give numbers. And look, I'm sorry if I missed this. I was late getting in on the call. But the -- what is the bed add number, excluding de novos, U.S. and U.K.? So it's just kind of same facility adding 20 beds here, 30 beds there?

    我喜歡你給出數字。另外,如果我漏聽了這段我很抱歉。我晚了一點才加入電話會議。不過——扣除新建(de novo)據點後,美國和英國的新增床位數是多少?也就是同一個院區這裡加20床、那裡加30床那種?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • David is looking that up. We have that number, I think.

    David 正在查。我想我們有那個數字。

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • Yes, John, we had 750 bed additions in -- for the full year. And about 160 of those were the 2 de novo facilities.

    是的,John,我們全年新增了750張床位。其中大約160張來自2家新建(de novo)院區。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • Okay. And what was the plan for this year?

    好的。那今年的計畫是什麼?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Now John, you didn't hear it in the beginning, you only get one question.

    John,你一開始沒聽到,你只能問一個問題。

  • Operator

    Operator

  • And next, we move on to Kevin Ellich with Craig-Hallum.

    接下來我們請 Craig-Hallum 的 Kevin Ellich。

  • Kevin Kim Ellich - Senior Research Analyst

    Kevin Kim Ellich - Senior Research Analyst

  • And I guess, we'll just follow up on John's question because I was going to ask it. Can you help us with the phasing of the 800 bed additions? Is that going to be spread evenly throughout the year? Or is it more weighted toward the back half?

    我想我就接著 John 的問題追問,因為我本來也要問這個。你們能否協助說明新增800床的時程分布?會平均分散在全年嗎?還是會比較集中在下半年?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • No, we can help you with the -- our estimate as of...

    可以,我們可以提供你——我們截至目前的估計……

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • And this is David. We do have more of a weighting towards the back half of the year as we look at the detail for 2018. So we have 150 or so in the first quarter, another 100 in the second quarter, with the remaining spaced somewhat evenly between the third and the fourth quarter.

    我是 David。就我們看2018年的細項而言,確實比較偏向下半年。第一季大約150床,第二季再約100床,剩下的在第三季與第四季之間大致平均分配。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • That's helpful. And then, Joey, I think you made a comment to Kevin's question about a -- in Q4, there was a drag that hurt patient day growth by about 70 basis points. Was that weather-related? Or could you give us the detail as to what the cause...

    這很有幫助。另外,Joey,我想你在回答 Kevin 的問題時提到——第四季有一個拖累,使病人日(patient day)成長大約少了70個基點。那是天氣因素嗎?或你能否提供原因的細節……

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • It was the hurricanes on the East Coast, including Puerto Rico; and we had one facility that had to be evacuated in California because of the fires.

    是東岸的颶風,包括波多黎各;另外我們在加州有一家機構因為野火必須撤離。

  • Operator

    Operator

  • And next, we move to Ana Gupte with Leerink Partners.

    接下來我們請 Leerink Partners 的 Ana Gupte。

  • Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

    Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

  • Wanted to get an update on the acute care JVs? And what are you seeing in terms of their willingness to maybe reduce the capacity of their behavioral wards? And are they kind of giving you performance guarantees on volume or payer mix? Any of the conversations you're having or anything you've inked.

    想請你更新一下急性照護合資(JV)的情況?你們看到他們在降低其行為健康病房容量方面的意願如何?他們是否會就量(volume)或付款方組合(payer mix)給你們某種績效保證?任何你們正在進行的對話或已簽訂的內容。

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • There's no guarantees in how many patient days they would be giving us. Now many of the joint ventures would close their psych units in their facilities and just use the new joint venture to treat all their patients. Occasionally, they want to keep a few psych med/surg beds for these psych patients that also has medical complications, and we get very comfortable with that. The main thing the joint venture partners are looking for is their being -- their emergency rooms have too many psych patients in them. And it's causing them staffing and risk issues that, quite frankly, they don't need. And that is something that a psych hospital can do. So we expect that their emergency room visits, and when they triage that psych patient, that, that psych patient would be using our freestanding joint venture. So that's the dynamics of the -- how the patients flow.

    他們不會保證會提供我們多少病人日。不過,許多合資夥伴會關閉其院內的精神科單位,改用新的合資機構來治療他們所有的病人。偶爾他們會想保留少數精神科的內外科(med/surg)床位,給同時有醫療併發症的精神科病人使用,對此我們也很能接受。合資夥伴主要在意的是——他們的急診室裡精神科病人太多。這造成他們在人力配置與風險上的問題,坦白說,他們不需要承擔這些。而這正是精神科醫院能處理的。因此我們預期,他們的急診就診在分流到精神科病人時,該精神科病人會使用我們的獨立式合資機構。這就是病人流向的動態。

  • Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

    Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

  • Okay. So it's not just Medicaid-heavy patient mix on -- in the ER on a Friday night or something. They will also send you...

    了解。所以不只是像週五晚上那種 Medicaid 比重很高的病人組合——在急診裡。他們也會把……送給你們?

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • It's all patients.

    是所有病人。

  • Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

    Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

  • Okay. All patients. Can you comment on the pricing trends in the U.S.? You might have said this on the call. I'm sorry if I missed it. I was on another call earlier.

    了解。所有病人。你能評論一下美國的定價趨勢嗎?你可能在電話會議中提過。如果我漏聽了很抱歉。我先前在另一通電話上。

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • The pricing trends, Medicare is going to give us in that 1% to 2% range, we think, closer to 2% because there is a little inflation this year. The states, we saw some good increases there at the beginning of this year, and the expansion to the opiate service also brings revenue to us. So if I was to take an average, we want commercial to give us somewhere between 3% to 6%. Medicaid is going to be in that 2% range with Medicare. Overall, if we get a 2%, 3% rate increase overall revenue per day, we would be very pleased.

    定價趨勢方面,我們認為 Medicare 會給我們約1%到2%的區間,因為今年有些通膨,我們覺得更接近2%。各州方面,我們在今年年初看到一些不錯的調升,而擴大鴉片類(opiate)服務也會為我們帶來收入。如果取個平均,我們希望商業保險能給我們約3%到6%。Medicaid 會和 Medicare 一樣大約在2%附近。整體而言,如果我們能拿到整體每日收入(revenue per day)2%、3%的費率調升,我們會非常滿意。

  • Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

    Anagha A. Gupte - MD, Healthcare Services and Senior Research Analyst

  • Okay, great. One final one, if I could. There was 2 dynamics going on with the short-term policies and the association health plans, which weakened essential health benefits quite a bit. On the other hand, all of the rhetoric around gun violence. I mean, how do you -- what kind of conversations are you having on potentially additional funding around mental health maybe that might be offsetting some of the other actions the Trump administration has taken to weaken essential health benefits. But they have a lot of pressure on the gun violence issue.

    好的,很好。最後一個問題,如果可以的話。短期保單和協會健康計畫(association health plans)有兩個動態,這些都相當程度削弱了基本健康福利(essential health benefits)。另一方面,圍繞槍枝暴力的各種言論。我的意思是,你們如何——你們在心理健康可能獲得額外資金方面,有哪些對話?這些資金是否可能抵銷川普政府採取的、削弱基本健康福利的一些作為?但他們在槍枝暴力議題上承受很大壓力。

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • We are very active working with some key senators and members of the house on protecting and expanding psychiatric benefits. And so it's just beginning, but we've had very positive conversations. I was there about 3 weeks ago meeting with these individuals and very positive, very receptive. Now no one wants to happen what happened in Florida, so I really don't comment on that very much. But it is a -- obviously, it's a sign that there's mental health issues that are not being addressed or getting through the system that should get -- that we should be catching. And anything we can do to assist any state or the federal government on where our thoughts are on this, we have open communications with the key committees and the key senators and congressmen on that issue.

    我們非常積極地與一些關鍵參議員及眾議院議員合作,以保護並擴大精神科福利。這才剛開始,但我們的對話非常正面。我大約三週前去那裡與這些人士會面,反應非常正向、也很願意聽。現在沒有人希望佛羅里達發生的事情再發生,所以我不太評論那件事。但顯然,那是一個訊號,顯示有些心理健康問題沒有被處理,或沒有在系統中被有效銜接,而這些本來應該——我們應該能及早捕捉到。我們能做的任何事來協助任何州或聯邦政府,分享我們對此的看法,我們都與關鍵委員會以及關鍵參議員與眾議員保持開放溝通。

  • Operator

    Operator

  • And we'll now move to our final question, Gary Taylor with JPMorgan.

    接下來我們進入最後一個問題,JPMorgan 的 Gary Taylor。

  • Gary Paul Taylor - Analyst

    Gary Paul Taylor - Analyst

  • Just one clarification. First, on the 4% to 6% same-store revenue growth expectation in U.K., that's constant currency number, correct?

    我只想確認一點。首先,英國同店營收成長4%到6%的預期,那是以固定匯率(constant currency)計算的數字,對嗎?

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • Yes.

    是的。

  • Gary Paul Taylor - Analyst

    Gary Paul Taylor - Analyst

  • Okay. Did I miss -- I missed just maybe the first 5 minutes, so I don't think I missed. Did you talk about CapEx maintenance and growth CapEx for '18?

    好的。我可能漏聽了——我大概錯過前5分鐘,所以我想我沒有漏太多。你們有談到2018年的維護性資本支出(CapEx maintenance)和成長型資本支出(growth CapEx)嗎?

  • David M. Duckworth - CFO, CAO and Controller

    David M. Duckworth - CFO, CAO and Controller

  • Gary, we didn't. We are projecting that maintenance CapEx would continue at historical levels, which is around 2% of our revenue. And then we do see our expansion CapEx opportunities for 2018, just with the number of new facilities and beds, being somewhere between $300 million to $350 million.

    Gary,我們沒有。我們預估維護性資本支出(maintenance CapEx)將會維持在歷史水準,約為我們營收的2%。另外,我們也看到2018年的擴張性資本支出(expansion CapEx)機會,考量新增設施與床位的數量,金額大約介於3億至3.5億美元之間。

  • Gary Paul Taylor - Analyst

    Gary Paul Taylor - Analyst

  • And then my last one, just coming back to the U.K. length of stay, and I know you talked about service mix, so I just want to understand -- make sure I'm understanding that correctly. When we look at that U.K. length of stay, first quarter was down about 35 days, 2Q was flat, 3Q was flat, 4Q is down about 24 days. So I'm just trying to understand if there's some seasonality to the service mix. Or if this weaker length of stay in the fourth quarter implies that the behavioral business was actually much weaker than the third quarter, and then education and health care, just more than filled the gap? So it just seems like really sizable swings that I don't feel like I understand it well.

    然後我最後一個問題,回到英國的平均住院天數(length of stay),我知道你談到服務組合(service mix),所以我只是想確認——確保我理解正確。我們看英國的住院天數,第一季大約下降35天,第二季持平,第三季持平,第四季下降約24天。所以我想了解,這是否與服務組合的季節性有關。或者第四季較弱的住院天數是否意味著行為健康業務其實比第三季弱很多,而教育與醫療保健則不僅補上缺口,甚至超過?這看起來像是非常大的波動,我覺得自己還沒有很理解。

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Well, Gary, I've got some people looking for some more detail. We do have the detail. We may have to give that to you off the line. But we have 6 very distinct programs in the U.K., which is very different than here in the U.S. In the U.S., the length of stay is usually around what is the payer's length of stay. The length of stay in the U.K. is around the service line length of stay. So if we had more patients in the acute part of the business, they have a 2-week length of stay; versus if you were in the forensic piece of our business, you could have 1 to 3 years. So it doesn't take many patients moving around in those service lines to impact the length of stay. And so we will have times when it will move more than someone would think it would move. And then we will have times where it stays very consistent. But admissions and discharges are so much smaller over there. They have more of an influence on the length of stay number than we have here in the U.S. So many times, I think people try to compare that piece to the U.S., but it's different in that it's not a payer length of stay. It is a specific service length of stay. Like a eating disorder in the U.K., a patient there could stay 3 to 6 months. So if you had more of one of the other or if we retrofitted a facility and brought back -- or brought a new eating disorder program, that could drive the length of stay one way. Or if we added acute beds, that could take the length of stay another way. The main thing is that we internally look at that and analyze that to see if there is anything unusual or -- going on there. But we're very comfortable with the length of stay, and that the service lines explain the change.

    嗯,Gary,我已經請一些人去看更詳細的資料。我們確實有明細。我們可能需要在電話會議結束後再提供給你。不過,我們在英國有6個非常明確區隔的方案(programs),這跟美國這邊很不一樣。在美國,住院天數通常大致取決於付款方(payer)的核定住院天數。而在英國,住院天數是依服務線(service line)的住院天數來看。所以如果急性(acute)業務的病人比較多,他們的住院天數是2週;相較之下,如果是在我們的司法精神科(forensic)業務,可能會住1到3年。因此,只要有少數病人在這些服務線之間移動,就會影響整體住院天數。所以有時候它的變動幅度會比一般人預期的更大。也會有一些時候它會非常一致。但英國那邊的收治(admissions)與出院(discharges)規模小得多。因此,它們對住院天數這個數字的影響,比我們在美國這邊更大。很多時候,我覺得大家會試著把這一塊拿來跟美國比較,但不同之處在於:它不是付款方的住院天數。它是特定服務的住院天數。例如在英國的飲食失調(eating disorder)服務,一位病人可能會住3到6個月。所以如果某一類服務的病人更多,或是我們改裝一個設施並重新引入——或新增一個飲食失調方案,就可能把住院天數往某個方向推動。或者如果我們增加急性床位,也可能把住院天數往另一個方向拉動。重點是,我們內部會看這些數據並加以分析,確認是否有任何不尋常的——情況正在發生。但我們對住院天數非常有信心,而且服務線足以解釋這些變化。

  • Gary Paul Taylor - Analyst

    Gary Paul Taylor - Analyst

  • Okay. I appreciate that. Yes, I certainly understand the various length of stays by those service lines. And maybe I'm just not appreciating how just a few patients might move these consolidated numbers more than one might first imagine, so I appreciate that. Maybe I'll follow up a little bit and just try to understand that makes the business a little better. But I appreciate it.

    好的。我很感謝你的說明。是的,我當然理解不同服務線會有不同的住院天數。也許我只是沒有充分意識到,少數幾位病人就可能讓這些合併後的數字比一開始想像的變動更大,所以我很感謝。我之後可能會再跟進一下,試著更理解這點,這也會讓我對業務的理解更到位一些。但我很感謝。

  • Operator

    Operator

  • And that will conclude today's question-and-answer session. I would now like to turn the call back over to Mr. Jacobs for any additional or closing remarks.

    以上為今天的問答環節。接下來我想把電話交回給Jacobs先生,請他做任何補充或結語。

  • Joey A. Jacobs - Chairman and CEO

    Joey A. Jacobs - Chairman and CEO

  • Well, thank you, operator. I want to thank the team in the field, our Acadia team here in the U.S. and in the U.K. Great job, great fourth quarter. We had some obstacles to overcome, and you all did a great job and positioned us to make our 2018 numbers. And I am very, very appreciative and more appreciative of the care you give to our patients and their families, that we are making a difference, we are improving their lives. And we never thank you all enough. We're also, in the U.K., very grateful to have a partner like NHS, that works with our teams. And we have that open line of communication, both on patients coming into the system and the care being delivered in the system. So we're very appreciative of that. I will be out visiting some facilities in the next 60 days and over to the U.K., so I'm looking forward to that travel. So once again, thank you all for a great fourth quarter. And we'll talk to you after the first quarter.

    好的,謝謝接線員。我要感謝第一線的團隊、我們在美國以及英國的Acadia團隊。做得非常好,第四季表現很出色。我們克服了一些障礙,而各位做得很棒,也讓我們具備達成2018年目標數字的條件。我非常、非常感激,也更感激你們對病患及其家屬提供的照護;我們正在帶來改變、正在改善他們的生活。我們對各位的感謝永遠不夠。另外,在英國,我們也非常感謝能有像NHS這樣的合作夥伴,與我們的團隊一起合作。我們也保持開放的溝通管道,無論是病患進入體系,或是在體系內提供的照護。因此我們對此非常感激。接下來60天內我會去拜訪一些設施,也會前往英國,所以我很期待這趟行程。再次感謝各位帶來出色的第四季表現。我們會在第一季之後再與各位通話。

  • Operator

    Operator

  • And that will conclude today's call. We thank you for your participation.

    今天的電話會議到此結束。感謝各位的參與。